Effect of double growth factor release on cartilage tissue engineering

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Stem Cell Biology

Background:

• Developing functional engineered cartilage requires precise control over cell behavior.
• Growth factors like insulin-like growth factor I (IGF-I) and growth factor β1 (TGF-β1) are crucial for chondrogenesis.
• Nanoparticle-mediated delivery systems offer potential for sustained and localized release of these factors.

Purpose of the Study:

• To investigate the effects of dual growth factor release on bone marrow mesenchymal stem cell proliferation and chondrogenic differentiation.
• To evaluate the efficacy of IGF-I and TGF-β1 delivered via poly(lactic acid-co-glycolic acid) (PLGA) and poly(N-isopropylacrylamide) (PNIPAM) nanoparticles on PLGA scaffolds.

Main Methods:

• Utilized PLGA and PNIPAM nanoparticles to encapsulate and control the release of IGF-I and TGF-β1.
• Assessed cell proliferation and differentiation on tissue culture polystyrene (TCPS) and macroporous PLGA scaffolds (200-400 µm pore size).
• Measured collagen type II and aggrecan expression as indicators of chondrogenic differentiation.

Main Results:

• On TCPS, TGF-β1 promoted proliferation, while IGF-I enhanced differentiation (collagen type II deposition).
• On PLGA scaffolds, the combination of IGF-I and TGF-β1 significantly increased collagen type II and aggrecan expression compared to single growth factors or no growth factors.
• Gradual release of both growth factors from nanoparticles demonstrated superior outcomes.

Conclusions:

• Dual delivery of IGF-I and TGF-β1 via nanoparticles from PLGA scaffolds is effective for enhancing engineered cartilage.
• This approach shows promise for improving the quality and functionality of engineered cartilage tissue.
• Sustained release of combined growth factors represents a significant advancement in cartilage tissue engineering.